retatrutide expanded access program eli lilly Retatrutide, Lilly's next generation of weight loss injections, showed dramatic results in clinical trials, with patients losing an average of up to 71.2 pounds, or 28.7% of their body weight. Eli Lilly announces more next-gen obesity

Noyou should not stop statin therapy without consulting your doctor, even if you start semaglutide

Common adverse effects included nausea, diarrhea and vomiting, which are consistent with similar therapies

How PlexusDx Delivers GLP-1 Without Insurance Requirements PlexusDx operates a straightforward model: complete a brief health questionnaire, consult with a licensed healthcare provider, and receive compounded GLP-1 medications shipped directly to your home

As clinical nutrition professionals, understanding food drug interactions is essential

In PMOS, they may be used when the clinical picture fits, especially when higher weight or metabolic risk is part of the case

Merchant TE, Conklin HM, Wu S, Lustig RH, Xiong X: Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine and hearing deficits